Directors Should Expect Questions About “Overboarding”
Corporate board members may want to reexamine whether sitting on two or more boards is in their long-term best interest. If they don’t, investors may be doing it for them.
Corporate board members may want to reexamine whether sitting on two or more boards is in their long-term best interest. If they don’t, investors may be doing it for them.
Corporate boards should take note that the situation at Progenics Pharmaceuticals has resulted in a proxy advisory firm validating a call for “shareholder board oversight.” Serving on a board that has been sighted for oversight by its investors could have an effect on future board appointments.
This article has been updated with corrections since it first appeared. Mylan, the generic and specialty pharmaceutical maker, last week agreed to consider a shareholder proposal that
On June 19, employees of Alphabet, the parent company of Google, protested the company’s labor practices and business policies at its annual meeting in Sunnyvale, Calif. Should worker concerns become a higher priority on corporate board agendas?
Now that State Street has identified climate change risk as a priority in the evaluation of its portfolio of companies, what does this mean for directors?
If your board hasn’t considered how environmental, social and governance (ESG) issues may affect your business model, supply chain and customers, it may be time it did.
Chief Executive Group exists to improve the performance of U.S. CEOs, senior executives and public-company directors, helping you grow your companies, build your communities and strengthen society. Learn more at chiefexecutivegroup.com.